Treatments

Professor Eva Havrdova from Charles University in Prague presented at the recent ECTRIMS Congress, where she discussed the use of Hematopoietic Stem Cell Transplantation (HSCT) for the treatment of multiple...

A short video summarising the key findings of a recent paper, titled "Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple...

A publication this week in BMJ Open has outlined a number of studies evaluating the use of stem cell therapy for people with progressive multiple sclerosis. These trials, being conducted by a team from...

Due to the lack of available treatment options for people with secondary progressive multiple sclerosis (SPMS), the development of novel therapies is vitally important. We sat down with Simon Wilkinson (CEO,...

A/Prof Helmut Butzkueven from the Melbourne Brain Centre speaks with us to help clear up the confusion surrounding the use of Stem Cell Therapy in multiple sclerosis. He explains how stem cells are currently...

Progressive MS is (finally) starting to be a major focus of MS research - both in trying to understand what triggers the shift from the relapsing-remitting form and in the development of effective treatments...

In recent years, a large focus of MS research around the world has been promoting remyelination - that is, the process of repairing damaged nerves. In a recent study published in Biomaterials Science, a team...

By Brett Drummond Spasticity is a common symptom in people with multiple sclerosis, having a major impact on quality of life and imposing a financial burden. There are a number of current treatments for...

Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest drug available for the treatment of MS, however, it has also...

The first Google Hangout gave members of our community an opportunity to chat with MS researcher and MStranslate co-founder, Brett...